🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨Excited to share our latest study in Journal of Crohn's and Colitis on the impact of GLP-1 RAs in #IBD patients! 🌟 Results show a reduction in poor outcomes, especially in those with higher BMI 📉. Could shape future research on treatments for #DM2 #Obesity in #IBD care. academic.oup.com/ecco-jcc/artic…

#Elderly #IBD patients w/ CDI seen as high-risk for complications. 🌍 Study: 654 patients, multicenter cohort. 📊 CDI not linked to post-discharge IBD complications/mortality up to 1 year post-discharge. Journal of Crohn's and Colitis Y-ECCO Henit Yanai academic.oup.com/ecco-jcc/advan…

Frailty rather than age matters when making decisions for older patients with IBD. Read our newest review in JCC. academic.oup.com/ecco-jcc/artic…

GLP-1 analogs are associated with improved IBD outcomes! Gorelik et al. iris dotan

Navigating Reproductive Care in Patients With #IBD Fantastic review by Paula Sousa Javier P. Gisbert Christian Selinger Mette Julsgaard Maria Chaparro At Journal of Crohn's and Colitis academic.oup.com/ecco-jcc/artic…

🎯 Navigating #Reproductive Care 🤰🏻 in Patients With #Inflammatory #Bowel #Disease 🔥 ✒️ Paula Sousa ✒️ 📘 in Journal of Crohn's and Colitis 🤗 👉tinyurl.com/5e57ptrd 🟣 Y-ECCO 🟣 ⚫️ Oxford University Press ⚫️ Maria Chaparro 🥰 Javier P. Gisbert Mette Julsgaard Christian Selinger 🔴 #IBD 🤱 #GITwitter 🔴

A bidirectional inflammatory-axis, characterized by “oralization” of stool microbiota community, between #periodontal disease, #salivary #dysbiosis, and #intestinal #inflammation, which may trigger #IBD flare-ups. Zilberstein et al. academic.oup.com/ecco-jcc/advan…

The substantial role of #sleep, #stress and #physical #activity in persistent high levels of #fatigue in patients with inflammatory bowel disease #IBD: A longitudinal trajectory study. Breeder et al. academic.oup.com/ecco-jcc/advan…

Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn’s Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies. Raja Atreya et al. academic.oup.com/ecco-jcc/advan…

Impact of #histological #remission for predicting clinical #relapse in Crohn’s disease #CD: a post-hoc analysis of the prospective #STORI cohort. Histology is not associated with clinical relaspe in CD! Reenaers et al. academic.oup.com/ecco-jcc/advan…

Characterisation of #IBD #heterogeneity using serum #proteomics, a first study by the IBD_COLLIBRI consortium. A multicentre study by Salomon and Sudhakar et al. Jonas Halfvarson Severine Vermeire Bram Verstockt academic.oup.com/ecco-jcc/advan…

Labour market participation and income in patients with IBD onset before young adulthood – the role of disease severity and mental health. Rasmussen et al. academic.oup.com/ecco-jcc/advan…